News
RCKT
--
0.00%
--
10 Pharmaceutical Stocks to Buy Today According to Tiger Cub Billionaire Lee Ainslie
In this article, we will take a look at 10 pharmaceutical stocks to buy today according to Tiger Cub Billionaire Lee Ainslie. You can skip our detailed analysis of Lee Ainslie’s history, investment strategy, and hedge fund performance, and go directly to s...
Insider Monkey · 5d ago
Managed Portfolio Series Buys Dynatrace Inc, Rocket Pharmaceuticals Inc, Sells CyberArk Software
GuruFocus News · 09/14 22:38
BRIEF-Rocket Pharmaceuticals Presents Phase 1 Data On Danon Disease Treatment At HFSA Meeting
reuters.com · 09/14 11:14
Rocket Pharmaceuticals Presents Clinical Data from RP-A501 Trial in Danon Disease at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2021
---- Data demonstrated RP-A501 was well tolerated and showed increasing and durable benefit --
Business Wire · 09/14 11:00
Rocket Pharmaceuticals Announces Upcoming Danon Disease Presentation at the Heart Failure Society of America Annual Scientific Meeting 2021
CRANBURY, N.J., September 10, 2021--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces that previously disclosed data fro...
Business Wire · 09/10 11:00
BRIEF-Rocket Pharmaceuticals Appoints Isabel Carmona As Chief Human Resources Officer
reuters.com · 09/07 11:35
Rocket Pharmaceuticals Appoints Isabel Carmona, J.D., as Chief Human Resources Officer
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces the appointment of Isabel Carmona, J.D., as chief human resources offi...
Business Wire · 09/07 11:00
WestRock Co. stock outperforms competitors on strong trading day
marketwatch.com · 09/02 21:30
WestRock Co. stock falls Wednesday, underperforms market
marketwatch.com · 09/01 21:30
WestRock Co. stock rises Tuesday, outperforms market
marketwatch.com · 08/31 21:30
WestRock Co. stock outperforms competitors despite losses on the day
marketwatch.com · 08/30 21:30
Rocket Pharma Stock Rises on Plan to Sell Stake to Largest Holder
Rocket Pharma, focused on gene therapies for childhood disorders, will place 812,516 shares with its largest holder, RTW Investments.
TheStreet.com · 08/30 10:06
WestRock Co. stock outperforms market on strong trading day
marketwatch.com · 08/27 21:31
WestRock Co. stock falls Thursday, underperforms market
marketwatch.com · 08/26 21:30
WestRock Co. stock rises Monday, still underperforms market
marketwatch.com · 08/23 21:30
WestRock Co. stock underperforms Tuesday when compared to competitors
marketwatch.com · 08/17 23:24
Affinity Asset Advisors, LLC Buys Vincerx Pharma Inc, Nautilus Biotechnology Inc, Protagonist ...
GuruFocus News · 08/17 18:38
Webull provides a variety of real-time RCKT stock news. You can receive the latest news about ROCKET PHARMACEU through multiple platforms. This information may help you make smarter investment decisions.
About RCKT
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is focused on developing gene therapy treatment options for rare, devastating diseases. The Company’s multi-platform development approach applies the well-established lentiviral vector (LVV) and adeno-associated viral vector (AAV) gene therapy platforms. The Company’s lead clinical program is a LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a genetic disease that leads to bone marrow failure and potentially cancer. Its additional pipeline programs for bone marrow-derived disorders are for Pyruvate Kinase Deficiency (PKD), Leukocyte Adhesion Deficiency-I (LAD-I) and Infantile Malignant Osteopetrosis (IMO). The Company is also developing an AAV-based gene therapy program for pediatric heart failure indication, Danon disease.